A QOL Value Survey for Quality-Adjusted Life Year (QALY) Estimation for MAC Pulmonary Disease (MAC-PD)

A QOL-Value Survey for Quality-Adjusted Life-Year (QALY) Estimation for Pulmonary Mycobacterium avium complex Pulmonary Disease (MAC-PD). - A QOL Value Survey for QALY Estimation for MAC-PD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049279

Enrollment

319

Registered

2022-10-22

Start date

2021-11-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-tuberculous mycobacterial pulmonary disease (NTM-PD) caused by Mycobacterium avium complex (MAC)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) General adults aged 20 years or older at screening (2) Individuals who are judged by the investigator to have adequate understanding of the conduct of the study (3) Those who agreed to participate in the study. (4) Persons who can complete the protocol-specified procedures (5) Individuals living in Japan at the time of screening

Exclusion criteria

Exclusion criteria: (1) Patients who have difficulty obtaining informed consent and conducting this study due to lack of Japanese language ability (2) Individuals who cannot participate in the survey

Design outcomes

Primary

Measure	Time frame
QOL values by severity in patients with MAC-PD.	—

Countries

Japan

Contacts

Public ContactTatsunori Murata

CRECON Medical Assessment Inc. NA

Tatsunori.murata@crecon.jp03-3407-4491

Outcome results